GST Reforms 2.0: Full list of over 40 stocks that can benefit from PM Modi’s Diwali promise
Prime Minister Narendra Modi's bombshell Independence Day announcement to overhaul India's GST structure by Diwali has sent shockwaves through Dalal ...
Tag: Benefit
Tata Elxsi shares turn ex-dividend tomorrow, last chance to buy for Rs 75 dividend benefit
Tata Elxsi shares will trade ex-dividend starting Wednesday, June 11, 2025, as the company has fixed the date as the ...
The threat to kick China out of U.S. exchanges is growing, and Hong Kong stands to benefit
Those exposed to Chinese ADRs—whether it’s a CEO of a U.S.-listed Chinese company, or an equity strategist dealing with the ...
Block’s 28% plunge in February leads fintech sell-off, while Stripe shows benefit of staying private
Patrick Collison, chief executive officer and co-founder of Stripe Inc., left, smiles as John Collison, president and co-founder of Stripe ...
How Elon Musk’s plan to slash government agencies and regulation may benefit his empire
Elon Musk's business empire is sprawling. It includes electric vehicle maker Tesla, social media company X, artificial intelligence startup xAI, ...
Benefit trend: Employers opt to give workers an allowance for health coverage
Dave Lantz is no stranger to emergency department or doctor bills. With three kids in their teens and early 20s, ...
Bajaj Housing looks well placed to benefit from rising housing demand
Issue dates: September 09-11, 2024Issue price: Rs 66-70Issue size: Upto Rs 6,560 croreImplied market cap: Upto Rs 58,297 croreFace value: ...
Study shows hormone therapy can benefit women’s health during menopause
Study shows hormone therapy can benefit women's health during menopause - CBS News
Sri Lanka among countries that could benefit from debt-for-nature swaps, says report
Debt-for-nature swaps, where poorer countries have debt written off in return for protecting ecosystems such as barrier reefs or rainforests, ...
ALS drug will be pulled from US market after study showed patients didn’t benefit
The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the ...
